‘Most Favored Nation’ pricing doesn’t actually put America first

GUEST COLUMN, Larry Bucshon
The White House just announced a sweeping plan that could ultimately cap U.S. drug prices at the lower levels seen in other developed countries.
Administration officials have good intentions. They’re trying to shake up the plainly unacceptable status quo, in which American “citizens pay massively higher prices than other nations pay for the same exact pill, from the same factory, effectively subsidizing socialism abroad,” as President Trump put it.